{"id":"W2753742685","doi":"10.1016/j.jid.2017.07.592","title":"397 Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ixekizumab; Psoriatic arthritis; Placebo; Adalimumab; Adverse effect; Internal medicine; Psoriasis; Population; Arthritis; Dermatology; Rheumatoid arthritis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188717,0.0002090219,0.001119669,0.0002895119,0.0001801468,0.00002699825,0.0002446974,0.0001022771,0.00002213567],"category_scores_gemma":[0.002440315,0.0001573571,0.00005793441,0.0001260006,0.0009424963,0.000422907,0.0001102825,0.0006656006,0.000003181732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006412494,"about_ca_system_score_gemma":0.0004110182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002011501,"about_ca_topic_score_gemma":0.0001629896,"domain_scores_codex":[0.9974276,0.0003782517,0.001216786,0.0002449306,0.0004652541,0.0002671866],"domain_scores_gemma":[0.9968742,0.0003373244,0.001633155,0.0004246988,0.000549329,0.0001813266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1361336,0.02437182,0.4945129,0.0002996669,0.003567573,0.005654458,0.08170729,0.0000830319,0.002064229,0.0002112146,0.001571766,0.2498225],"study_design_scores_gemma":[0.1147506,0.006157265,0.8706545,0.0007239467,0.0001004713,0.00009766553,0.002834578,0.00007874762,0.003944805,0.0003651802,0.0001566273,0.0001356117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970081,0.0002528066,0.00001140729,0.001628806,0.00006344425,0.0007298107,0.00005439984,0.000004662692,0.0002464902],"genre_scores_gemma":[0.9994011,0.00008363535,0.0003354364,0.0001002142,0.00003117407,0.000006588639,0.00001680702,0.00001777787,0.000007258059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3761416,"threshold_uncertainty_score":0.6416835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02908035995489525,"score_gpt":0.3204822035978377,"score_spread":0.2914018436429425,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}